[ad_1]
Health Minister Arūnas Dulkys stated that the European Commission (EC) has agreed with BioNTech and Pfizer an additional 200 million euros. dose of vaccine. According to the Ministry, taking into account the latest agreements, Lithuania would need LTL 1.24 million pro rata. additional doses of vaccine.
“We would offer what belongs to Lithuania proportionally through that opportunity, and we would use it to adjust our previous decision accordingly,” the minister said.
EC offer to acquire an additional 310 thousand. Modern vaccine doses have been rejected by the government. A. Dulkys emphasized that the pharmaceutical company had increased its price by a third, as well as the delivery conditions for unsatisfied vaccines in Lithuania.
“Because Moderna raises the price and does not want to distribute it in the same terms – it increases that price by 33 percent more than what is specified in the contract, and because it does not improve the terms, but forecasts them only at the end of the year, our group working amendments and not making this addition ”, said the Minister.
In Lithuania, more than 27,000 people have already been vaccinated against the first dose of coronavirus. population. As of Wednesday, only BioNTech and Pfizer were used in the country, and the Moderna vaccine was introduced on Wednesday. In both cases, immunity to COVID-19 is acquired only after the second dose of the vaccine.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
